Xenetic Biosciences, Inc.
XBIO
$3.99
$0.112.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -8.55% | 5.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.55% | 5.63% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -8.55% | 5.63% | |||
| SG&A Expenses | -6.96% | -5.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.15% | 56.95% | |||
| Operating Income | 14.26% | -120.04% | |||
| Income Before Tax | 14.36% | -141.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.36% | -141.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.36% | -141.47% | |||
| EBIT | 14.26% | -120.04% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 14.36% | -141.45% | |||
| Normalized Basic EPS | 14.37% | -141.47% | |||
| EPS Diluted | 14.36% | -141.45% | |||
| Normalized Diluted EPS | 14.37% | -141.47% | |||
| Average Basic Shares Outstanding | 0.00% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||